关注
Ilya V Gordeychuk
Ilya V Gordeychuk
其他姓名Илья Гордейчук, Ilya Gordeichuk
Chumakov FSC R&D IBP RAS
在 chumakovs.su 的电子邮件经过验证
标题
引用次数
引用次数
年份
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies
LI Kozlovskaya, AN Piniaeva, GM Ignatyev, IV Gordeychuk, VP Volok, ...
Emerging microbes & infections 10 (1), 1790-1806, 2021
762021
Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak
L Kozlovskaya, A Piniaeva, G Ignatyev, A Selivanov, A Shishova, ...
International Journal of Infectious Diseases 99, 40-46, 2020
542020
Impact of universal hepatitis B vaccination on prevalence, infection-associated morbidity and mortality, and circulation of immune escape variants in Russia
VV Klushkina, KK Kyuregyan, TV Kozhanova, OE Popova, PG Dubrovina, ...
PLoS One 11 (6), e0157161, 2016
422016
HIV1 Reverse Transcriptase Promotes Tumor Growth and Metastasis Formation via ROSDependent Upregulation of Twist
E Bayurova, J Jansons, D Skrastina, O Smirnova, D Mezale, ...
Oxidative Medicine and Cellular Longevity 2019 (1), 6016278, 2019
272019
Проблемы скрытой инфекции, вызванной вирусом гепатита В
ИА Морозов, ЛЮ Ильченко, НИ Громова, ИГ Фёдоров, ИВ Гордейчук, ...
Рос. журн. гастроэнтерол., гепатол., колопроктол 22 (4), 58-66, 2012
272012
Therapeutic vaccines against human papilloma viruses: achievements and prospects
MS Vonsky, AL Runov, IV Gordeychuk, MG Isaguliants
Biochemistry (Moscow) 84, 800-816, 2019
252019
DNA immunization site determines the level of gene expression and the magnitude, but not the type of the induced immune response
S Petkov, E Starodubova, A Latanova, A Kilpeläinen, O Latyshev, ...
PLoS One 13 (6), e0197902, 2018
232018
A heterologous virus-vectored vaccine for prevention of Middle East respiratory syndrome induces long protective immune response against MERS-CoV
AV Kovyrshina, IV Dolzhikova, DM Grousova, MV Balyasin, AG Botikov, ...
Immunology 41 (2), 135-143, 2020
22*2020
The evaluation of pharmacodynamics and pharmacokinetics of anti-thrombin DNA aptamer RA-36
E Zavyalova, N Samoylenkova, A Revishchin, A Turashev, I Gordeychuk, ...
Frontiers in Pharmacology 8, 922, 2017
222017
Групповая заболеваемость гепатитом Е в г. Коврове Владимирской области (Предварительное сообщение)
МИ Михайлов, ЕЮ Малинникова, КК Кюрегян, ОЕ Исаева, ...
Труды Института полиомиелита и вирусных энцефалитов имени МП Чумакова РАМН …, 2009
222009
Vaccination with oral polio vaccine reduces COVID-19 incidence
NV Yagovkina, LM Zheleznov, KA Subbotina, AA Tsaan, LI Kozlovskaya, ...
Frontiers in Immunology 13, 907341, 2022
212022
Серологические маркеры инфицирования вирусами гепатитов среди условно здорового населения Республики Тыва
ТВ Кожанова, ЛЮ Ильченко, ВВ Клушкина, ВС Кичатова, НВ Соболева, ...
Труды Института полиомиелита и вирусных энцефалитов имени МП Чумакова РАМН …, 2013
20*2013
ATM and ATR expression potentiates HBV replication and contributes to reactivation of HBV infection upon DNA damage
A Kostyusheva, S Brezgin, E Bayurova, I Gordeychuk, M Isaguliants, ...
Viruses 11 (11), 997, 2019
192019
Safety and Immunogenicity of Inactivated Whole Virion COVID-19 Vaccine CoviVac in Clinical Trials in 18–60 and 60+ Age Cohorts
IV Gordeychuk, LI Kozlovskaya, AA Siniugina, NV Yagovkina, VI Kuzubov, ...
Viruses 15 (9), 1828, 2023
14*2023
Immunity and viral infections: modulating antiviral response via CRISPR–Cas systems
S Brezgin, A Kostyusheva, E Bayurova, E Volchkova, V Gegechkori, ...
Viruses 13 (7), 1373, 2021
142021
Replenishment of hepatitis B virus cccDNA pool is restricted by baseline expression of host restriction factors in vitro
S Brezgin, A Kostyusheva, E Bayurova, I Gordeychuk, M Isaguliants, ...
Microorganisms 7 (11), 533, 2019
142019
Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
AI Tukhvatulin, IV Gordeychuk, IV Dolzhikova, AS Dzharullaeva, ...
Emerging Microbes & Infections 11 (1), 2229-2247, 2022
132022
Оценка иммунологической эффективности массовой вакцинации против гепатита В
ТВ Кожанова, ВВ Клушкина, ИВ Гордейчук, КК Кюрегян, МИ Михайлов
Труды Института полиомиелита и вирусных энцефалитов имени МП Чумакова РАМН …, 2014
112014
Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9
D Kostyushev, A Kostyusheva, S Brezgin, N Ponomareva, NF Zakirova, ...
Molecular Therapy-Nucleic Acids 31, 482-493, 2023
92023
Preclinical studies of immunogenity, protectivity, and safety of the combined vector vaccine for prevention of the Middle East respiratory syndrome
DM Grousova, OV Zubkova, AI Tukhvatulin, AV Kovyrshina, NL Lubenets, ...
Acta Naturae (англоязычная версия) 12 (3 (46)), 114-123, 2020
8*2020
系统目前无法执行此操作,请稍后再试。
文章 1–20